title: Chryseobacterium indologenes, a possible emergent organism resistant to carbapenem antimicrobials after stem cell transplantation.
abstract: A 64-year-old female was diagnosed with adult T-cell leukemia/lymphoma. She then underwent an unrelated allogeneic bone marrow transplantation with a reduced-intensity regimen. She achieved engraftment followed by HHV-6 encephalopathy. This was complicated byChryseobacterium indologenespneumonia.Chryseobacterium indologenesis now a possible emergent organism resistant to carbapenem after transplantation.
authors.affiliation: Division of Hematology and Stem Cell Transplantation Department of Internal Medicine Faculty of Medicine Kagawa University Kagawa Japan.
authors.forename: Osamu
authors.initials: O
authors.lastname: Imataki
authors.affiliation: Division of Hematology and Stem Cell Transplantation Department of Internal Medicine Faculty of Medicine Kagawa University Kagawa Japan.
authors.forename: Makiko
authors.initials: M
authors.lastname: Uemura
keywords: Adult T‐cell leukemia/lymphoma; Chryseobacterium indologenes; carbapenem; pneumonia; stem cell transplantation